We don't know whether the most recent response to this request contains information or not – if you are BEN HOLDSWORTH please sign in and let everyone know.

Treatment with Specified Products

BEN HOLDSWORTH made this Freedom of Information request to Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust as part of a batch sent to 214 authorities Automatic anti-spam measures are in place for this older request. Please let us know if a further response is expected or if you are having trouble responding.

We're waiting for BEN HOLDSWORTH to read a recent response and update the status.

BEN HOLDSWORTH
Delivered

Dear Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust,

Could you please provide answers to the following questions, with regards to treatments with the specified products:

1) in the past 6 months, how many patients were treated with a combination of both Encorafenib (Braftovi) + Binimetnib (Mektovi) for the following diseases:

A) Metastatic Melanoma
B) Colorectal Cancer
C) Any other indications

2) In the past 6 months, how many patients were treated with a combination of Dabrafenib + Trametinib for the following diseases:
A) Metastatic Melanoma
B) Adjuvant Melanoma
C) BRAF mutated Lung Cancer

Thank you for answering these questions

Yours faithfully,
BEN HOLDSWORTH

Link to this Report
WRAITH, Diane (DONCASTER AND BASSETLAW TEACHING HOSPITALS NHS FOUNDATION TRUST), Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust

1 Attachment

Dear Ben, 

 

Please find attached our response to your Freedom of Information request.

 

Kind regards,

 

 

Diane Wraith

Admin Assistant

Communications and Engagement

Doncaster and Bassetlaw Teaching Hospitals

NHS Foundation Trust

T:01302 644246

E: [1][email address]

 

show quoted sections

Link to this Report
We don't know whether the most recent response to this request contains information or not – if you are BEN HOLDSWORTH please sign in and let everyone know.